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Objective 
To determine whether breaking up prolonged sitting with short bouts of standing or walking 
improves post-prandial markers of cardio-metabolic health in women at high risk of type 2 
diabetes. 
 
Research Design and Methods 
Twenty-two overweight/obese, dysglycaemic, postmenopausal women (mean age ± SD: 
66.8±4.6 years) each participated in two of the following treatments; prolonged, unbroken 
sitting (7.5 hours) or prolonged sitting broken up with either standing or walking at a self-
perceived light-intensity (for 5 minutes every 30 minutes). Both allocation and treatment 
order were randomised. The incremental area under the curves (iAUC) for glucose, insulin, 
non-esterified fatty acids (NEFA) and triglycerides were calculated for each treatment 
condition (mean ± SEM). The following day, all participants underwent the 7.5 hours sitting 
protocol.  
 
Results 
Compared to a prolonged bout of sitting (iAUC 5.3±0.8mmol/L•h), both standing (3.5±0.8) 
and walking (3.8±0.7) significantly reduced the glucose iAUC (both p<0.05). When 
compared with prolonged sitting (548.2±71.8mU/L•h), insulin was also reduced for both 
activity conditions (standing: 437.2±73.5; walking: 347.9±78.7; both p<0.05). Both standing 
(-1.0±0.2mmol/L•h) and walking (-0.8±0.2) attenuated the suppression of the NEFA 
compared with prolonged sitting (-1.5±0.2); both p<0.05. There was no significant effect on 
triglyceride iAUC. The effects on glucose (standing and walking) and insulin (walking only) 
persisted into the following day. 
 
Conclusions 
Breaking up prolonged sitting with 5-minute bouts of standing or walking at a self-perceived 
light-intensity reduced postprandial glucose, insulin and NEFA responses in women at high 
risk of type 2 diabetes. This simple, behavioural approach could inform future public health 
interventions aimed at improving the metabolic profile of post-menopausal, dysglycaemic 
women. 
 
 
 
3 
 
Sedentary behaviour, now commonly conceptualised as sitting during waking hours with low 
energy expenditure (1), has recently emerged as an independent determinant of morbidity 
(particularly type 2 diabetes) and mortality (2-4).  Multiple observational studies have also 
demonstrated a positive association between objectively measured sedentary time and 
markers of diabetes risk, independent of the amount of moderate-to-vigorous physical activity 
(MVPA) undertaken (5-7). This suggests that sedentary behaviour is likely to be a distinct 
risk factor for type 2 diabetes and a potential target for lifestyle intervention. This is 
important as individuals at high risk of type 2 diabetes spend around 70% of their waking 
time sedentary, with 25% in light activity and <5% engaged in MVPA (6). Moreover, the 
inverse correlation between sedentary behaviour and MVPA is weak (7), further suggesting 
these are independent behaviours. However, experimental data are needed to determine 
whether a causal relationship exists between modifications to sedentary time and metabolic 
health.   
 
Recently, experimental studies which have broken up prolonged sitting with short periods of 
light or moderate intensity activity have been shown to reduce postprandial glucose and 
insulin concentrations in both healthy and overweight adults (8-11). These studies suggest 
that important health-related metabolic processes occur when individuals transition from 
sitting to movement (light and moderate intensity). However, it is unclear whether moving 
from sitting to standing provides a sufficient stimulus to elicit metabolic benefits. Whilst 
there is emerging evidence that sustained bouts of standing may improve glucose regulation 
(12, 13), it is not clear whether breaking up prolonged sitting with intermittent short bouts of 
standing might improve the metabolic health of individuals at high risk of chronic disease.  
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Therefore, the aim of this study was to establish whether breaking up prolonged sitting 
through frequent short bouts of standing or walking activity modulates postprandial 
metabolic responses in individuals at high risk of type 2 diabetes. 
 
Research Design and Methods 
 
Study design 
 
A balanced incomplete block design was utilised for this study (14). Such designs have been 
used in pharmaceutical trials and reduce participant burden whilst minimising the intra-
subject effect, thus increasing the sensitivity of the outcome (15, 16). With this design, 
participants were randomised to two of the three following treatment conditions: 1) 
prolonged, unbroken sitting (7.5 hours); 2) prolonged sitting broken up with standing for 5 
minutes every 30 minutes or 3) prolonged sitting broken up with walking for 5 minutes every 
30 minutes (Supplemental Table S1). Regardless of the treatment condition carried out on 
day 1, all participants underwent the prolonged sitting protocol on day 2, thus each treatment 
condition was carried out over two consecutive days. As an acute bout of physical activity 
may enhance insulin sensitivity for up to 48 hours (17), we used a minimum wash-out period 
of 7 days between each condition (the maximum wash-out was 22 days). 
 
Participants attended five separate visits to the Leicester Diabetes Centre, Leicester, UK. 
Supplemental Figure 1 describes the study design. One to two weeks after an initial 
familiarisation visit, participants were randomised by an independent third party to one of six 
sequences, prepared by the study statistician prior to recruitment of the first participant 
(Supplemental Table S1).  
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The study is registered with clinicaltrials.gov (NCT02135172). Informed consent was 
obtained from all eligible participants and ethical approval was obtained from the 
Northampton Research Ethics Committee. 
 
Participants 
 
A total of 34 participants were recruited between January 2014 and October 2014. Post-
menopausal women at high risk of developing type 2 diabetes were identified from studies 
previously conducted within the Leicester Diabetes Centre (18, 19). This cohort was included 
in order to negate the impact of hormone variations and as associations between sedentary 
behaviour and markers of cardio-metabolic health have previously been shown to be stronger 
in women (20). 
 
Eligibility criteria included: overweight or obese (BMI ≥27.5 kg/m2 or ≥25 kg/m2 if south 
Asian), post-menopausal women (12 consecutive months without menstruation (21)), aged 
50-75 years with screen detected impaired glucose regulation (IGR) identified within the 12 
months prior to the invitation letter being sent. IGR was defined as 2 hour post-challenge 
glucose ≥7.8mmol/L to <11.1mmol/L following a standard oral glucose tolerance test (22), or 
HbA1c between 5.7-6.4% (39-46mmol/mol) inclusive (23). Exclusion criteria were regular 
purposeful exercise (≥150 minutes of objectively measured MVPA over a typical week), 
inability to communicate in spoken English, steroid use, known type 2 diabetes, or currently 
taking hormone replacement medication.  
 
In total, 30 participants were randomised (Figure 1). Causes of drop out between 
familiarisation and randomisation are detailed in Figure 1. A further 8 individuals were 
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excluded after randomisation, due to cessation of the venous cannula line which resulted in 
less than 50% of data collection (n=5), illness (n=2), or a change in personal circumstance 
(n=1). This left 22 participants that were included in the analysis. There were no significant 
differences in BMI, age or HbA1c between those who dropped out or were excluded and 
those who were included in the study.  
 
Familiarisation visit 
 
Before participating in the experimental protocol, all participants visited the Leicester 
Diabetes Centre for a familiarisation visit where they provided informed consent. This 
allowed participants to become accustomed to the walking speed and also familiarize 
themselves with the Borg rating of perceived exertion (RPE) scale (24). A venous blood 
sample was also taken for HbA1c, lipid profile, and non-esterified fatty acids (NEFA) 
analysis.  
 
Body mass (Tanita TBE 611, Tanita, West Drayton, UK), waist circumference (midpoint 
between the lower costal margin and iliac crest), and height were measured, to the nearest 
0.1kg, 0.5cm and 0.5cm respectively.  
 
Participants also wore an accelerometer (placed on the right anterior axillary line) for seven 
days after familiarisation (Actigraph GT3X+, Pensacola, FL, USA) to measure time spent 
engaged in sedentary, light or MVPA, under free-living conditions.  
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Experimental regimen overview 
 
Participants were asked to record all food and drink consumed the day before the first 
experimental condition. They were then asked to replicate this diet before subsequent 
treatments. Participants were also requested to avoid alcohol, caffeine and any MVPA for 
two days prior to each experimental condition.  
 
Participants arrived at the laboratory by car (08:00) after a 10 hour fast and had a cannula 
fitted into an accessible vein. A fasting blood sample (9ml) was then taken (time point: -1 h) 
for the quantification of glucose, insulin, NEFA and triglycerides. Participants were asked to 
sit quietly for 60 minutes and a further 9ml blood sample was taken. A standardised mixed-
meal breakfast (croissant, butter, cheese, double cream, skimmed milk and a meal 
replacement drink (Complan, Nutricia Limited, Wiltshire, UK)) was consumed (09:00; 0 h) 
providing 0.66g fat, 0.66g carbohydrate and 0.4g protein per kg of body mass (58% fat, 26% 
carbohydrate and 16% protein). The time taken to consume the meal (≤15 minutes) was 
recorded and replicated in subsequent conditions. Blood was sampled again at 30, 60, 120 
and 180 minutes postprandially. Lunch, with an identical nutrient composition to breakfast, 
was consumed at 12:00 with blood samples at 30, 60, 120, 180 and 210 minutes 
postprandially. The research staff supervised participants throughout each study cycle to 
ensure full compliance with the trial protocols. Participants consumed water ad libitum 
during the first of the experimental conditions and were then asked to replicate the volume 
ingested in subsequent conditions.  
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Experimental Regimens – Day 1  
 
Experimental Condition: Prolonged sitting (7.5 hours) 
 
During the prolonged sitting condition, walking and standing was restricted (lavatory visits 
were conducted via a wheelchair). Participants sat in a designated room equipped with a 
chair, desk and access to books, magazines and internet services.  
 
Experimental Condition: Sitting (total 6.5 hours) + Standing (total 60 minutes) 
 
This followed the same procedure as the sitting condition except that participants were 
instructed to break their sitting time by standing close to their chair for 5 minutes, every 30 
minutes. Individuals were asked to stand in the same, fixed position. In total, individuals 
accumulated 12 bouts (60 minutes) of standing. 
 
Experimental Condition: Sitting (total 6.5 hours) + Walking (total 60 minutes) 
 
This was similar to the standing condition, but sitting time was punctuated with 5 minute 
bouts of walking at a self-perceived light intensity on a treadmill (Spazio Forma Folding 
Treadmill, TechnoGym UK Ltd, Bracknell, UK). During the first bout of walking, 
participants were gradually taken up to a speed that registered between 10 and 12 on the Borg 
RPE scale (24), up to a maximum of 4.0 km/h. This speed was fixed and replicated for all 
other intervals. In total, individuals accumulated 12 bouts (60 minutes) of walking.  
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The average treadmill speed during the walking condition was 3.0km/h (range =1.5-4.0km/h) 
with an average RPE score of 10 (range 8-12). 
 
Experimental Regimens – Day 2 (Prolonged sitting – 7.5 hours) 
 
To determine whether any acute effects of standing and walking persisted into the next day, 
participants returned to the laboratory (08:00) following another 10 h fast to undergo the 
prolonged sitting protocol (including the same standardised meals and timings). They were 
asked to consume exactly the same meal as the previous evening – whilst again avoiding 
alcohol, caffeine and MVPA.  
 
Sedentary, physical activity and posture data  
 
Participants were asked to wear an accelerometer (Actigraph GT3X+, Pensacola, FL, USA) 
and an activPAL professional physical activity monitor (PAL Technologies, Glasgow, 
Scotland), during experimental conditions and an accelerometer for 7 days before each 
experimental condition (Supplemental Figure 1).  
 
ActivPAL proprietary software (activPAL Professional V5.9.1.1) was used to create 
processed csv files. 
 
For accelerometer data collected over each 7 day period, non-wear time was defined as a 
minimum of 60 minutes of continuous zero counts and days with at least 10 h of wear time 
were considered valid (5, 6). Valid data required at least three valid days (25). Freedson cut 
points were used to categorise activity intensity (26). Accelerometer data were analysed using 
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a bespoke tool (KineSoft version 3.3.76, KineSoft, New Brunswick, Canada; 
www.kinesoft.org). 
 
Biochemical analysis 
 
Plasma glucose and serum triglyceride concentrations were determined using standard 
enzymatic techniques with commercially available kits (Beckman, High Wycombe, UK). The 
measurement of plasma NEFA involved a three stage colorimetric assay using a 
commercially available kit (RX Monza, Randox Laboratories, County Antrim, UK). Glucose, 
triglycerides and NEFA were analysed on the day of collection. 
 
Insulin samples underwent centrifugation to separate plasma within 15 minutes of collection. 
Plasma was stored at -80oC and analysed at the end of data collection using an enzyme 
immuno-assay (Mercodia, Sweden). All measurements and analysis were undertaken by 
individuals blinded to experimental condition and independent of the scientific advisory 
team. 
  
Sample size 
 
The primary outcome was incremental postprandial area under the glucose curve (iAUC) on 
day 1. Allowing for an intervention effect of a 20% change in glucose iAUC, a standardised 
difference of 1 (where the SD is equivalent to the anticipated intervention effect), a within-
person correlation of 0.3, 90% power, and an alpha of 0.025 (allowing for two primary 
comparisons against control conditions), we estimated that we would require 12 participants 
for a complete 3-treatment, 3-period crossover design. Twice as many participants were 
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required for the 3-treatment, 2-period balanced incomplete block design (27), and a 20% 
drop-out rate was allowed for; therefore we aimed to recruit 30 participants with 24 needed to 
complete the trial. Estimates were based on previous experimental research (8), and with 
consideration given to the high risk nature of our cohort where a greater effect was 
anticipated.  
 
Statistical Analyses 
 
In line with best practice for acute studies where fasting physiology does not change, 
outcomes were calculated as iAUC rather than total AUC (28). Values were determined using 
the trapezium rule and by subtracting fasting levels from the overall postprandial response.  
 
Participants were excluded if they had over 50% of blood samples missing across any 
treatment condition (n=5). Missing outcome data for remaining participants were imputed 
using a regression model with key predictor variables (BMI, age, fasting values, ethnicity and 
treatment) for each time point and outcome. Imputation was used to correct for verification 
bias (29). Across all experimental conditions, 11% of data values (378/3472) were missing 
and imputed (Supplemental Table S2)On average, participants were missing 2 (1-4) (median 
(IQR) values across all experimental days and biochemical variables. 
 
Multilevel mixed-effects linear regression was used to look at the difference between groups 
in the continuous outcome measures (glucose, insulin, NEFA, triglycerides) allowing for 
repeated measurements from the same individuals. In these models, treatment was modelled 
as a fixed factor and participant as a random factor. The primary analysis involved comparing 
standing and walking against the control (prolonged sitting) condition. Tests between 
12 
 
treatment conditions (standing vs. walking) were conducted for exploratory purposes and 
form a secondary outcome for the study. 
 
All data were analysed using STATA (version 13.0; StataCorp, College Station, TX).  A p-
value of <0.05 was considered statistically significant. Descriptive data are reported as mean 
± SD in text and tables, unless otherwise stated, and as mean ± SEM in Figure 2, Figure 3 and 
Supplemental Tables S3-S6. 
 
In order to aid interpretation of the results, a sensitivity analysis was conducted to investigate 
whether results were affected by analysing the total AUC (including fasting values). 
Furthermore, we also investigated whether fasting values differed between day 1 and day 2 
(Supplemental Table S7). 
 
 
Results 
 
Anthropometric, biochemical and demographic information of the included participants are 
displayed in Table 1. 
 
Experimental Regimens – Day 1 
 
Biochemical results collected on day 1 (for each experimental condition) are presented in 
Figure 2, with the corresponding numerical values displayed in Supplemental Table S3. 
 
The mean glucose iAUC response (iAUC) was 5.3±0.8mmol/L•h in the prolonged sitting 
condition. Breaking sitting time with 5 minutes of standing, every 30 minutes, reduced the 
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glucose iAUC by 34% (3.5±0.8mmol/L•h, p=0.022) compared with prolonged sitting. 
Similarly, walking reduced the glucose iAUC by 28% (3.8±0.7mmol/L•h, p=0.009) 
compared with prolonged sitting.  
 
A similar pattern of results were observed for insulin and NEFA on day 1. The insulin iAUC 
was reduced by 20% (437.2±73.5mU/L•h, p=0.045) when breaking sitting time with standing 
and by 37% (347.9±78.7mU/L, p=0.008) when it was broken with walking compared with 
prolonged sitting (548.2±71.8mU/L•h). Breaking sitting time with standing attenuated the 
suppression of the NEFA iAUC by 33% (-1.0±0.2mmol/L•h, p=0.024), and with walking by 
47% (-0.8±0.2mmol/L•h, p=0.003) compared with prolonged sitting (-1.5±0.2mmol/L•h).  
 
There were no significant differences between the standing and walking conditions for any of 
these outcomes (glucose p=0.717, insulin p=0.376, NEFA p=0.398).  
 
Conversely, neither standing (6.2±0.8mmol/L•h) nor walking (6.1±0.8mmol/L•h) 
significantly reduced the triglyceride iAUC compared with the sitting condition 
(5.6±0.7mmol/L•h) on day 1. 
 
Experimental Regimens – Day 2 (Prolonged sitting – 7.5 hours) 
 
17 participants completed the second day due to problems with intravenous cannulation. 
Biochemical results for day 2 are presented in Figure 3 with the corresponding numerical 
values displayed in Supplemental Table S4.  
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Day 2 yielded a mean net glucose response of 4.8±0.6mmol/L•h if participants had 
undertaken the sitting condition on day 1. Breaking sitting time with standing on day 1 
elicited a response of 3.9±0.8mmol/L•h on day 2 (19% reduction in iAUC compared to 
sitting, p=0.039). Similarly, walking carried out on day 1 reduced the glucose iAUC by 17% 
on day 2 (4.0±0.7mmol/L•h, p=0.027). There was no significant difference between the 
standing and walking conditions (p=0.877). 
 
The mean net insulin response was 464.6±70.2mU/L•h if participants had undertaken the 
sitting condition on day 1. The significant results for standing on day 1 did not persist into the 
second day (363.5±57.5mU/L•h, p=0.325). In contrast, results for walking persisted into day 
2 (354.3±57.3U/L•h p=0.038). There was no significant difference between the standing and 
walking conditions (p=0.529). 
 
There was no difference in triglyceride response between the prolonged sitting 
(7.2±0.5mmol/L•h) and standing conditions (7.2±0.8mmol/L•h, p=0.603) on day 2. Results 
for the walking condition (6.0±0.7mmol/L•h, p=0.077) neared significance compared to 
prolonged sitting. 
 
The effects of standing and walking on NEFA were no longer significant on day 2 (standing: 
-1.0±0.3mmol/L•h, p=0.161; walking: -1.0±0.3mmol/L•h, p=0.144) when compared to 
prolonged sitting (-1.5±0.2mmol/L•h). 
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Sensitivity analysis 
 
The pattern of results and significance levels were largely unaffected if the data were 
analysed using total AUC on day 1 (Supplemental Table S5). However, total AUC on day 2 
failed to reach significance for both glucose (standing and walking condition) and insulin 
(standing only) (Supplemental Table S6). Conversely, results for NEFA became significant 
for both standing and walking. There were no significant differences between any fasting 
values on day 1 or day 2 (Supplemental Table S7).  
 
Sedentary and physical activity data 
 
Free-living accelerometer data collected after the familiarisation visit (n=22) (Supplemental 
Table S8) showed that participants spent 594±80 minutes per day sedentary (71.5% of total 
wear time) and only engaged in modest amounts of MVPA (19±10 minutes per day; 2% of 
total wear time); there was no difference in these behaviours for the 7-days prior to each 
experimental conditions (p>0.05).  
 
The Actigraph and activPAL monitor data recorded during the experimental conditions 
confirmed that compliance to the protocol was high (Supplemental Tables S8 and S9). 
Participants took an average 6±2 steps and 252±18 steps during each 5-minute standing and 
walking bout respectively. 
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Conclusions 
 
In overweight, post-menopausal women with dysglycaemia we observed that interrupting 
periods of prolonged sitting with 5 minutes of standing every 30 minutes elicits similar 
changes to postprandial glucose metabolism as breaking up sitting with identical periods of 
self-perceived light-intensity walking. Compared with uninterrupted sitting, standing reduced 
the postprandial rise in glucose by 34% (compared with a 28% reduction for walking) and the 
postprandial rise in insulin concentrations by 20% (37% for walking) on the day of the 
intervention. Moreover, the observations for glucose (standing and walking) and insulin 
(walking only) persisted into the next day. 
 
These data build on previous work in overweight men and women (8) reporting similar 
glucose and insulin postprandial responses after light and moderate intensity walking. The 
present findings extend these observations by suggesting that metabolic benefits are also 
accrued when regularly breaking up prolonged sitting by moving from a sitting to a stationary 
upright posture.  
 
To date, four other studies have examined the acute effect of standing on postprandial 
glucose and insulin responses (12, 13, 30, 31). Two of these found that breaking prolonged 
sitting with regular standing breaks had no impact on postprandial glucose (30, 31) and 
insulin (30) in young healthy men. In contrast, alternating 30 minute bouts of sitting and 
standing throughout the day has been shown to significantly reduce the iAUC between trial 
conditions for postprandial glucose (11% reduction compared to prolonged sitting) (12). A 
non-randomised office-based study also found that glucose levels were reduced by 43% 
following an afternoon of standing compared with seated computer work (13).  The fact that 
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our study reported effects that were towards the upper end of those reported in previous 
studies, whilst employing substantially smaller doses of standing, is likely to be driven by 
differences in sample characteristics and potentially the increased frequency in interruptions 
to prolonged sitting. Other studies have been conducted in groups that are broadly 
representative of the general population (age <50 years, BMI <30kg/m2), whereas our 
participants were older with existing dysglycaemia who represent those likely to be referred 
into diabetes prevention pathways. This is particularly important given the prominence of 
national and international strategies highlighting the need for identification and subsequent 
referral of individuals at high risk of type 2 diabetes (32, 33).  
 
Another novel finding was that reductions in glucose and insulin responses following the 
breaking up of prolonged sitting were maintained into the second observation day. Glucose 
remained 19% lower after the standing condition and 17% lower after the walking condition. 
Similarly, insulin remained 24% lower after the walking condition. These findings are 
consistent with a previous experimental study carried out in obese adults showing that a 
single bout of modest exercise (50% VO2 peak on a stationary cycle ergometer) increased 
insulin sensitivity into the next day (11). A similar study also demonstrated that the morning 
after a prolonged bout of sitting (17 hours), participants exhibited a significant reduction 
(39%) in whole-body insulin action compared to upright light-intensity activity (10). Our 
findings indicate that an even lower activity stimulus (e.g.: standing) may yield metabolic 
advantages for a minimum of 24 hours.  
 
The mechanisms underpinning the effects of standing and walking on glucose and insulin 
levels requires further elucidation. Acute and chronic light-intensity physical activity training 
studies have consistently demonstrated improvements in markers of glycaemic control in 
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those with dysglycaemia, with similar effects observed between light and moderate intensity 
exercise training regimes, when matched for total volume (34). However, it has not been 
established whether the specific mechanisms involved in enhancing peripheral glucose uptake 
that have been shown for MVPA, primarily through the translocation and turnover of GLUT-
4 (35), are observed with walking at a self-perceived light intensity or standing.  
 
The attenuated postprandial suppression in plasma NEFA concentration observed on day 1 of 
this study for both the standing and walking is likely to reflect an increase in the lipolysis of 
triglycerides stored in adipose tissue in order to supply the working muscle. Moreover, the 
reduction of insulin in the standing and walking conditions suggests that suppression of 
lipolysis, driven by the antilipolytic properties of insulin (36), may have been reduced in 
these conditions. Previous studies have shown that during low-intensity exercise, adipose 
tissue lipolysis increases four-to fivefold above resting levels (37). Others have also reported 
that lipolysis and mobilization of NEFA resulting from exercise are related to, and may be 
enhanced by, hormonal changes, particularly increased catecholamines levels (38). 
 
We found no change in the triglyceride iAUC for the standing and walking conditions on 
either day 1 or day 2 of the experimental regimens. The non-significant results on day 1 are 
consistent with previous studies that have shown no effect (9, 12). Decreased triglyceride 
levels were observed on day 2 following the walking condition, although the changes were 
not statistically significant (17% reduction compared to sitting, p=0.077). However, the 
magnitude of the effect for walking on day 2 was consistent with previous studies 
demonstrating that walking (both intermittent and continuous) elicited reductions in the 
postprandial triglyceride levels the following day (16-23% reduction). Our results corroborate 
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with other findings suggesting that standing is not a sufficient stimulus to reduce postprandial 
triglyceride levels (12, 30).   
 
This study has a number of strengths. Firstly, we studied postmenopausal women at high risk 
of type 2 diabetes, so the findings are directly relevant for public health guidance and 
interventions for metabolic risk reduction. Secondly, this is the first study to directly compare 
the effects of breaking up prolonged sitting with standing and walking, demonstrating that 
they both induce cardio-metabolic benefits. Moreover, by employing a two day protocol we 
were able to determine that the acute effects of standing and walking persisted into the 
following day.  Our study also highlights the importance of reporting both iAUC and total 
AUC in experimental studies that assess outcomes over several days. Although results on day 
1 were unaffected by the analysis method there were small differences in interpretation on 
day 2. Notwithstanding the non-significant differences in mean fasting levels on day 2, it is 
possible that the intervention conditions had a subtle effect on fasting pathophysiology that 
subsequently influenced total AUC. As such, results should be interpreted in relation to the 
method used; for this study the primary focus was on the postprandial response (iAUC). 
Finally, all measurements were performed by the same team of trained staff, following 
identical standard operating procedures and analysis was conducted by individuals blinded to 
treatment allocation.  
 
This study has several important limitations. Firstly, the acute nature of the trial prohibits 
inferences about longer-term chronic effects. Secondly, the test meals used were relatively 
high in fat (58% of total energy) and further studies are needed in order to determine whether 
the findings persist when meals with a macronutrient composition more representative of 
dietary recommendation are consumed. However, the macronutrient composition of food was 
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almost identical to that which may be plausibly consumed by the general population through 
a meal or as a snack. For example, based on an 80kg individual the standardised meal used in 
this study is equivalent to 46g brown bread, 6g butter, 100g bacon and a 59g chocolate bar 
(39). Studies have also indicated that the recommended daily intake of fat is often exceeded 
by many adults (40). We also relied upon participants to record and standardise their own 
food intake the day before and in-between each experimental conditions for practical reasons, 
therefore misreporting is possible. Similarly, no physical activity data was recorded between 
day 1 and day 2. Thirdly, the prolonged nature of the sitting condition may not reflect 
habitual behaviour for many individuals where some standing or light movement would be 
expected over an 8 hour period. Nonetheless, it was important to initially establish a proof of 
concept where standing and walking effects are observed compared to a prolonged 
standardised bout of sitting. Future studies should also focus on whether the effects observed 
in this study are replicated under free living scenarios. The reduced sample size (and 
subsequent underpowered comparison) particularly pertaining to comparisons on day 2 
increased the risk of a type 2 error and thus limits the conclusions that can be drawn over the 
second day. Furthermore, the study was not designed to assess differences between the 
standing and walking conditions which were included as a secondary outcome. Finally, 
further research is needed to determine whether the effects can be generalized to men and 
premenopausal women.   
 
In conclusion, this study demonstrates that breaking up prolonged sitting with 5-minute bouts 
of standing or walking at a self-perceived light intensity reduces postprandial glucose, insulin 
and NEFA responses in post-menopausal women at high risk of type 2 diabetes. This simple, 
behavioural approach could inform future public health interventions aimed at improving the 
metabolic profile of dysglycaemic individuals. Habitual standing and light-intensity physical 
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activity are behaviourally more ubiquitous than MVPA and may therefore provide appealing 
interventional targets in the promotion of metabolic health. However, future behavioural 
intervention studies are needed to investigate the most effective methods of reducing habitual 
sedentary behaviour within a prevention context and to assess generalizability beyond post-
menopausal women.  
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Figure 1. Study CONSORT Diagram 
 
121 participants invited from previous type 2 diabetes prevention projects 
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Table 1. Metabolic, demographic and anthropometric characteristics at baseline and dietary and 
physical activity variables during the study (n=22) 
 
 
 
Baseline characteristics  
Age (years) 66.6 ± 4.7 
Current smoker 1 (4.5) 
BMI (kg/m2) 32.9 ± 4.7 
Waist circumference (cm) 102 ± 9.0 
Body mass (kg) 83.6 ± 11.7 
Total cholesterol (mmol/L) 5.60 ± 0.87 
Triglycerides (mmol/L) 2.17 ± 0.86 
Non-esterified fatty acids (mmol/L) 0.44 ± 0.24 
HbA1c (%) 5.8 ± 0.2 
HbA1c (mmol/mol) 40 ± 2.3 
Fasting plasma glucose (mmol/L) 5.4 ± 0.4 
Lipid lowering medication 5 (22.7) 
Beta-blockers 5 (22.7) 
ACE Inhibitors 3 (13.6) 
Ethnicity 
White European 
Black and minority ethnic  
 
20 (90.9) 
2 (9.1) 
In study characteristics 
Diet 
Total energy intake (kcal/day) 
Total fat (energy %) 
Total carbohydrate (energy %) 
Total protein (energy %) 
 
1717 ± 234 
58 ± 0.2 
26 ± 0.1 
 16 ± 0.2 
Walking speed (km/h) 3.0 (1.5-4.0) 
Borg rate of perceived exertion score 10 (8-12) 
 
Data are presented as mean±standard deviation, number (%) or mean (range) 
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Figure 2. The effect of sitting, standing and walking upon glucose (A), insulin (B) NEFA (C) and 
triglyceride (D) levels on day 1  (n=22) 
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Figure 3. The effect of sitting, standing and walking upon glucose (A), insulin (B) NEFA(C) and 
triglyceride (D) levels on day 2 (n=17) 
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Mean (± SEM) glucose, insulin,NEFA and triglycerideson day 1 (Figure 2; A, B, C, D) and day 2 
(Figure 3; A, B, C, D) measured over a 6.5-h period during the prolonged sitting, sitting and 
standing and sitting and walking conditions. Standardised meals provided at 0h and 3h. iAUC; 
incremental area under the curve, SEM; standard error of the mean, NEFA; non-esterified fatty 
acids 
 
